Kenneth C. Cundy, SVP, Preclinical Development at XENOPORT INC (XNPT), sold 1,000 shares at $42.90 ($42K) on 2008-11-03, disclosed to the SEC on 2008-11-05.
Scheduled sale ($42k) by SVP, Preclinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.12 | 100 | $4K | 9.8% |
| 2 | $41.43 | 100 | $4K | 9.9% |
| 3 | $41.56 | 100 | $4K | 9.9% |
| 4 | $41.72 | 100 | $4K | 9.9% |
| 5 | $41.83 | 100 | $4K | 10.0% |
| 6 | $41.85 | 100 |
| $4K |
| 10.0% |
| 7 | $42.20 | 100 | $4K | 10.0% |
| 8 | $42.66 | 100 | $4K | 10.2% |
| 9 | $42.88 | 100 | $4K | 10.2% |
| 10 | $42.90 | 100 | $4K | 10.2% |
| Total | $42.02 avg | 1,000 | $42K | 100% |
| Filing → |
| CWBR | SELL | 2020-08-10 | $19K | — | Filing → |
| CWBR | SELL | 2020-06-17 | $24K | — | Filing → |
| CWBR | SELL | 2020-05-18 | $26K | — | Filing → |